Health
Medical
Cancer Prevention

VolitionRX

$3.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-3.10%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VolitionRX and other stocks, options, ETFs, and crypto commission-free!

About

VolitionRX Limited Common Stock, also called VolitionRX, is a multi-national life sciences company. It engages in the development of blood-based cancer tests to help diagnose a range of cancers. Read More Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.

Employees
44
Headquarters
Singapore, Central Singapore
Founded
2010
Market Cap
128.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
89.33K
High Today
$3.38
Low Today
$3.23
Open Price
$3.38
Volume
13.05K
52 Week High
$3.63
52 Week Low
$1.44

Collections

Health
Medical
Cancer Prevention
Asia (Non-China)
Asia

News

Yahoo FinanceApr 24

VNRX: Entry Into China, Taiwan Large Lung Cancer Study and Animal Diagnostics Subsidiary

By Brian Marckx, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Capital Markets Day Update Following reporting of Q4 earnings in mid-March, VolitionRx (VNRX) had a spate of news leading up to their ‘Capital Markets Day on April 9th at the New York Stock Exchange. The news is an extension of the product development related updates provided during the Q4 earnings call, which as a reminder, included new (i.e. initial) ‘proof-of-concept’ study data from the first round of ‘product grade’ assays in...

18

Earnings

-$0.17
-$0.15
-$0.13
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
-$0.12 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.